Publications by authors named "Juliane Quinkhardt"

Claim this Profile
D
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity.
Alexander Muik, Homer C Adams 3rd, Friederike Gieseke, Isil Altintas, Kristina B Schoedel, Juliane Quinkhardt

J Immunother Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors.
Alexander Muik, Elena Garralda, Isil Altintas, Friederike Gieseke, Ravit Geva, Juliane Quinkhardt

Cancer Discov· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Ugur Sahin, Petra Oehm, Evelyna Derhovanessian, Robert A Jabulowsky, Mathias Vormehr, Juliane Quinkhardt

Nature· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A liposomal RNA vaccine inducing neoantigen-specific CD4 T cells augments the antitumor activity of local radiotherapy in mice.
Nadja Salomon, Fulvia Vascotto, Abderaouf Selmi, Mathias Vormehr, Juliane Quinkhardt

Oncoimmunology· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma.
Shelly Kalaora, Yochai Wolf, Tali Feferman, Eilon Barnea, Erez Greenstein, Juliane Quinkhardt

Cancer Discov· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis